This episode of the Nano Entrepreneurship Network podcast features a conversation between NNCO Director Lisa Friedersdorf and Rui Jing Jiang, Co-Founder, CEO, and Director of Avisi Technologies. Ms. Jiang discusses how she started this company to develop a nanotechnology-based medical device to treat glaucoma. If you would like to learn more about nanotechnology, go to nano.gov or email us at info@nnco.nano.gov. Closed captioning is provided on our YouTube channel. For this episode, go to: https://youtu.be/_ka2dg5DVHw CREDITS Special thanks to: Rui Jing Jiang Avisi Technologies Music: Teamwork by Scott Holmes https://freemusicarchive.org/music/Sc... https://creativecommons.org/licenses/... Produced by: Andrew Pomeroy Any opinions, findings, conclusions, or recommendations expressed in this podcast are those of the guest and do not necessarily reflect the views of the National Nanotechnology Coordination Office or United States Government. Additionally, mention of trade names or commercial products does not constitute endorsement or recommendation by any of the aforementioned parties. Any mention of commercial products, processes, or services cannot be construed as an endorsement or recommendation.
This episode of the Nano Entrepreneurship Network podcast features a conversation between NNCO Director Lisa Friedersdorf and Rui Jing Jiang, Co-Founder, CEO, and Director of Avisi Technologies. Ms. Jiang discusses how she started this company to develop a nanotechnology-based medical device to treat glaucoma.
If you would like to learn more about nanotechnology, go to nano.gov or email us at info@nnco.nano.gov.
Closed captioning is provided on our YouTube channel. For this episode, go to: https://youtu.be/_ka2dg5DVHw
CREDITS
Special thanks to:
Rui Jing Jiang
Avisi Technologies
Music:
Teamwork by Scott Holmes
https://freemusicarchive.org/music/Sc...
https://creativecommons.org/licenses/...
Produced by:
Andrew Pomeroy
Any opinions, findings, conclusions, or recommendations expressed in this podcast are those of the guest and do not necessarily reflect the views of the National Nanotechnology Coordination Office or United States Government. Additionally, mention of trade names or commercial products does not constitute endorsement or recommendation by any of the aforementioned parties. Any mention of commercial products, processes, or services cannot be construed as an endorsement or recommendation.